ARCHIVES

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

This article is from The Cancer Letter archive.

Vol. 22 No. 35 | September 13, 1996

Download PDF Visit The Full Archive

Related Articles

Pastan’s Laboratory Creates “Chimeric” Monoclonal Antibody With Human, Muse

August 12, 1988

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Henry Brem Named Director Of Neurology At Johns Hopkins.

July 28, 2000

Biostatisticians Write To Varmus Asking NCI To Investigate

July 23, 2010

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

NCI-Approved Clinical Trials

October 29, 2004